Rosa Mónica, Penacho Nuno, Simöes Sérgio, Lima Maria C P, Lindman Björn, Miguel Maria G
Chemistry Department, University of Coimbra, Portugal.
Mol Membr Biol. 2008 Jan;25(1):23-34. doi: 10.1080/09687680701499451.
A study related to the development and characterization of a new gene delivery system was performed. The approach consists in both the pre-condensation of plasmid DNA with an arginine-based cationic surfactant, arginine-N-lauroyl amide dihydrochloride (ALA), which was found not to be toxic, and the incorporation of the blood protein transferrin (Tf) into the formulations. Two cationic liposome formulations were used, one composed of a mixture of dioleoyl trimethylammoniopropane and cholesterol (DOTAP:Chol) and the other a pH sensitive formulation constituted of DOTAP, Chol, Dioleoyl phosphatidylethanolamine (DOPE) and cholesteryl hemisuccinate (CHEMS). Particles with different ALA/DNA and cationic lipid/DNA charge ratios were produced and a physicochemical characterization of the systems developed was performed. DNA conformational changes in the presence of ALA were studied by Circular Dichroism (CD) and the ALA binding to DNA was followed by surface tension measurements. Insight into the structure and morphology of the various ALA-complexes (complexes composed of ALA, DNA, Tf and liposomes) was obtained by cryogenic-Transmission Electron Microscopy (cryo-TEM) and the sizes of the ALA-complexes were determined through Photon Correlation Spectroscopy (PCS). We found that the transfection capacity of these systems is directly related with the presence of ALA and the lipidic composition. Complexes based on the pH sensitive liposome formulation present better transfection profiles. The correlation between the inner structure, density and size of the ALA-complexes and their biological activity is discussed. Overall, we demonstrate that the presence of ALA improves the transfection efficiency when conjugated with cationic liposome systems.
开展了一项关于新型基因递送系统的开发与特性研究。该方法包括用一种基于精氨酸的阳离子表面活性剂——精氨酸 - N - 月桂酰酰胺二盐酸盐(ALA)对质粒DNA进行预缩合,已发现ALA无毒,以及将血液蛋白转铁蛋白(Tf)掺入制剂中。使用了两种阳离子脂质体制剂,一种由二油酰基三甲基氯化铵和胆固醇(DOTAP:Chol)的混合物组成,另一种是由DOTAP、Chol、二油酰基磷脂酰乙醇胺(DOPE)和胆固醇半琥珀酸酯(CHEMS)构成的pH敏感制剂。制备了具有不同ALA/DNA和阳离子脂质/DNA电荷比的颗粒,并对所开发的系统进行了物理化学表征。通过圆二色性(CD)研究了在ALA存在下DNA的构象变化,通过表面张力测量追踪ALA与DNA的结合。通过低温透射电子显微镜(cryo-TEM)深入了解了各种ALA复合物(由ALA、DNA、Tf和脂质体组成的复合物)的结构和形态,并通过光子相关光谱法(PCS)测定了ALA复合物的大小。我们发现这些系统的转染能力与ALA的存在和脂质组成直接相关。基于pH敏感脂质体制剂的复合物具有更好的转染特性。讨论了ALA复合物的内部结构、密度和大小与其生物活性之间的相关性。总体而言,我们证明当ALA与阳离子脂质体系统结合时,其存在可提高转染效率。